Billy Tauzin

Jason Linkins

Former Legislators Can Get Staggeringly Rich Peddling Influence, In Case You'd Somehow Forgotten This

HuffingtonPost.com | Jason Linkins | Posted 03.15.2012

If the example of Senator Olympia Snowe is any guide, then the typical "Why I Am Leaving Congress" op-ed is fairly similar to Greg Smith's now-famous ...

'Nonprofit' Means Personal Wealth For CEOs

The Huffington Post | Max Rosenthal | Posted 12.20.2011

WASHINGTON -- The chief executives of major companies are frequently blasted for their massive salaries, but new reports show that the heads of the na...

Cost Of Broken Health Care System Is Killing Us

Rev. Jesse Jackson | Posted 02.05.2012

Rev. Jesse Jackson

The U.S. pays far higher prices for the drugs than other industrial nations, even though U.S. taxpayers often have paid to invent the drugs. How could this be?

Amanda Terkel

The Ghosts Of Health Care Deals Past

HuffingtonPost.com | Amanda Terkel | Posted 05.25.2011

WASHINGTON -- The deals that the White House cut with major industries during the health care debate are threatening to come back to haunt the adminis...

Which Retiring Senators Will Be Working for Wall Street Next Year?

Mike Lux | Posted 05.25.2011

Mike Lux

All of the senators and House members working on financial reform should pledge right now that they will not retire only to go work for the likes of Goldman Sachs, Citibank, or JP Morgan Chase.

Did Filibuster Reform Lead Sen. Bayh to Quit?

Michael Kieschnick | Posted 05.25.2011

Michael Kieschnick

Bayh blamed lack of bipartisanship for his decision, but of all the potential reasons for his leaving the senate, this one is the most likely to be bogus.

The Legacy of Billy Tauzin: The White House-PhRMA Deal

Paul Blumenthal | Posted 05.25.2011

Paul Blumenthal

Within a few months of being sworn in, the President and his aides were sitting down with leaders from the pharma industry to hash out a deal that they thought would make health care reform possible.

Billy Tauzin Leaving Pharma: Top Lobbyist For Drugmakers Stepping Down

AP | ERICA WERNER | Posted 05.25.2011

WASHINGTON — The head of the influential trade association for drug manufacturers announced Thursday night that he is leaving his job. The deve...

Ryan Grim

After Ripping Clinton And McCain, Obama Embraces Their Policies

HuffingtonPost.com | Ryan Grim | Posted 05.25.2011

In an interview with The Washington Post on Tuesday, President Barack Obama challenged his critics to identify any "gap" between what he campaigned ...

Medicare Part D Creators Now Working For Lobbyists With Billions At Stake

ProPublica | Olga Pierce | Posted 05.25.2011

Four years ago, a group of lawmakers and aides crafted Medicare Part D, the prescription drug program for seniors that has produced billions of dollar...

What If Health Reform Passes?

Mark Blumenthal | Posted 05.25.2011

Mark Blumenthal

My column this week looks at the evolution of impressions of the Medicare prescription drug benefit among seniors in the years following its passage a...

An Open Letter to Jane Smiley: Please Don't Believe Everything You Read

Maggie Mahar | Posted 05.25.2011

Maggie Mahar

Based on what the mainstream press has been reporting, the president is letting us down. But the truth is, the press is just engaging in a time-honored media sport: first build someone up then tear him down.

Obama on Drugs: 98% Cheney?

Greg Palast | Posted 05.25.2011

Greg Palast

When Cheney was caught having secret meetings with oil companies, we denounced it as a case of foxes in the henhouse. But Obama's secret meetings, he assures us, are in the public interest.

Health-Care Reform was the Key Issue in the 2008 Campaign...What Happened?

Joseph A. Palermo | Posted 05.25.2011

Joseph A. Palermo

For some, the system works best when elites make the most fundamental decisions for our society, unencumbered by the trappings of "democracy", and when the population is depoliticized, misinformed, or both.

Why Aren't Progressive Groups Protesting Obama's Back-Room Deal with Big Pharma?

Miles Mogulescu | Posted 05.25.2011

Miles Mogulescu

Progressives were outraged when the Bush administration banned Medicare from negotiating for lower drug prices. It's time for outrage when the Obama administration does the same.

The White House Deal with Big Pharma

James Love | Posted 05.25.2011

James Love

The White House has abandoned any real effort to control costs in the pharma sector and Democrats have taken this hands-off approach as a green light to side with Big Pharma.

Obama Embraces Drug Lobbyist He Targeted During Campaign

Los Angeles Times | Tom Hamburger | Posted 05.25.2011

As a candidate for president, Barack Obama lambasted drug companies and the influence they wielded in Washington. He even ran a television ad targetin...

Salon: Blue Dogs Put Corporate Interests Over Party, Constituents

Salon | Posted 05.25.2011

Nobody could be better positioned than the Democrats who call themselves "Blue Dogs" to sabotage healthcare reform, the primary objective of their pre...

Dems & Repubs on Health Care: 'Love a Lobbyist'

Michele Swenson | Posted 05.25.2011

Michele Swenson

The same insurance and pharmaceutical lobbies have granted themselves billions of dollars of taxpayer subsidies and inflated profits continue to shape the healthcare reform debate today.

Sam Stein

PhRMA CEO Urges GOP To Work With Obama On Health Care, But Won't Compromise Himself

HuffingtonPost.com | Sam Stein | Posted 05.25.2011

A key industry official in the health care debate praised the Obama administration on Tuesday for taking an "us"-oriented approach when it came to rev...